Background and objectives:
The study of biomarkers of dietary patterns including the Mediterranean diet (MedDiet) is scarce and could improve the assessment of these patterns. We aimed to determine a robust and accurate biomarker associated with a high adherence to a MedDiet pattern that included dietary assessment and its biological effect.
Methodology:
In this cross-sectional study we included 56 and 63 individuals with high (H-MDA) and low (L-MDA) MedDiet adherence categories, respectively, all from the Prevención con Dieta Mediterránea trial. A 1 H-NMR-based untargeted metabolomics approach was applied to urine samples.
Multivariate statistical analyses were conducted to determine the metabolite differences between groups, as well as to build and evaluate the prediction model for H-MDA.
Results and conclusions:
Thirty-four metabolites were identified as discriminant between H-MDA and L-MDA. The H-MDA included higher excretion of food metabolome metabolites, and decreased amounts of metabolites related to glucose metabolism. The microbial metabolites: phenylacetylglutamine, p-cresol and 4-hydroxyphenylacetate were included in the prediction model of H-MDA, thus being the biomarker that defined high adherence to the MedDiet. The overall metabolite profiling identified reflects the metabolic modulation produced by H-MDA. The proposed biomarker may be a better tool for assessing and aiding nutritional epidemiology in future associations between H-MDA and the prevention or amelioration of chronic diseases.
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